Simlatus Corporation (OTCPINK: SIML),stock was up +52.35% to $0.0009 at previous close. It has performed a total of -7.14% over a period of five days, with a 5-day range of $0.0015 to $0.0035. For the past month, this stock’s price fluctuated between $0.0010 and $0.0088, for a gain of 136.36%. For the last three months, the price of this stock rose by 1,200.00%, trading between $0.0002 and $0.0088.
Most Recent Simlatus Corporation Development
On March 04, 2021, Simlatus Corporation revealed a partnership with BrewBilt Manufacturing Inc. (BBRW) and the BrewBilt Brewing Company.
- Two of the Best Pharmaceutical Stocks to Watch for in 2021
- 3 Best Gene Therapy Stocks for long-term Investment
According to CEO Jef Lewis, today is a historical day for Simlatus. The Company will be filing the PRE14C this month in preparation for building the brewery. The brewery has been purchased by SIML, and it will be licensed to operate by summer 2021. It will enable brewery business owners and people seeking contract breweries to make craft beer to capture revenue. Companies will cooperate in terms of marketing and sales. Over the next 36 months, beer sales are estimated to range from $25M- to $125M. Projected revenues for breweries are expected to be $250M over the next 48 months.
Simlatus Corporation (OTCPINK: SIML) Operation Highlights
A company that offers multiple revenue streams operates mainly in the CBD Industry, Broadcast Media Industry, and Internet Providers Industry. In addition to manufacturing the first commercially available cold-water CBD extraction system for medical-grade cannabis applications, Proscere Bioscience also manufactures advanced aeroponic control containers with commercial-grade technology for food-safety programs, commercial and medical grade CBD.